about
sameAs
Physiotherapy for Parkinson's disease: a comparison of techniquesSpeech and language therapy versus placebo or no intervention for speech problems in Parkinson's diseaseEvaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complicationsInterventions for reducing anxiety in women undergoing colposcopyInterventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in overweight and obese peopleElectronic retrieval of health information by healthcare providers to improve practice and patient careAdjuvant chemotherapy and/or radiotherapy after surgery for uterine carcinosarcomaEvaluation of the efficacy and safety of adjunct treatment to levodopa therapy in Parkinson's disease patients with motor complicationsInterventions for reducing anxiety in women undergoing colposcopyOccupational therapy for patients with Parkinson's diseaseChemotherapy and/or radiotherapy after surgery for ovarian carcinosarcomaLaparoscopically assisted radical vaginal hysterectomy versus abdominal radical hysterectomy for the treatment of early cervical cancerEvaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatmentCatechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's diseaseCatechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's diseaseThe effectiveness of the public release of performance data in changing consumer, healthcare professional or organisational behaviourAmantadine for dyskinesia in Parkinson's diseaseTherapies for depression in Parkinson's diseaseBeta-blocker therapy for tremor in Parkinson's diseaseAmantadine in Parkinson's diseaseRopinirole for levodopa-induced complications in Parkinson's disease.Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.Developing a service user informed intervention to improve participation and ability to perform daily activities in primary Sjögren's syndrome: a mixed-methods study protocol.Cabergoline for levodopa-induced complications in Parkinson's disease.Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.A comparison of physiotherapy techniques for patients with Parkinson's disease.Non-pharmacological therapies for dysphagia in Parkinson's disease.Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic reviewSpeech and language therapy for dysarthria in Parkinson's disease.A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.Occupational therapy for patients with Parkinson's disease.Physiotherapy for patients with Parkinson's Disease: a comparison of techniques.Systematic review of antidepressant therapies in Parkinson's disease.Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial.Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis.Patient directed self management of pain (PaDSMaP) compared to treatment as usual following total knee replacement: study protocol for a randomized controlled trial.The Northampton Physical Health and Wellbeing Project: the views of patients with severe mental illness about their physical health checkAn evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health.Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.
P50
Q24193978-77523CC9-95D7-4EB8-9E1F-DB08970E630FQ24201565-DB6EC08C-0D19-4F93-A0CC-A9ECAFC7EEC2Q24234273-B9D95AE0-138C-41C9-8A6F-28BA3A6BF595Q24234507-E01BA35E-84E5-4062-BB50-F9B3C95CC72FQ24236596-57C3C171-28DE-4469-8EAE-348F171761ACQ24240210-D893B66C-80BE-4D15-9079-BF9C8BE374BAQ24243090-9235F384-4FBE-4BFF-BA06-6ECE9A75E7B3Q24243535-E05ED770-879A-48DD-B699-2D184F0A96A0Q24243825-ED854FA0-EC3A-48AD-88C3-89A91B2A97C8Q24243925-D3468115-FEF3-4B88-A751-FE2F63E62C67Q24244489-9DA59E4A-1420-4A51-8420-E378739053F9Q24244511-31A2DCD7-071F-44ED-A380-FD4F14624AA7Q24245763-147622ED-CED4-45BD-A7EB-D4F490F23B07Q24245911-4F29F76B-5559-4A21-9E77-2A082832EBD6Q24246072-33E4469A-321C-4548-AB38-A1F21178B29AQ24247836-B78A3BC2-B3D3-42B9-BD21-D34519614C03Q24248660-B9404FEE-A98B-467B-A00B-F4784F72EBAAQ24248733-36C78559-57C5-4A4E-B50B-E414667E6F5BQ24250185-0BF78421-5633-471D-B752-D5C503C7AB16Q24250281-509A12C0-2C07-43AE-BC4F-687EA467C670Q33978400-EF508D8D-2288-4473-A53F-FE27F4770FFAQ33978408-EB44AC45-2685-4FD6-9175-3C232D0471F3Q34144965-4792A4C8-4C08-4F51-9DBC-B21A3D2F6B45Q34202356-9B0EE7C1-1E41-466C-A62B-9E1A4B0FE0DDQ34202365-32BE52C6-20A4-4A83-A3AF-66DE73E869E2Q34202614-13AB856A-96D1-4BD6-987E-6E7D084F844DQ34202621-FA72E9B0-2CB8-44AA-A609-5788BF83C835Q34245935-9B3EAD19-A46B-43E8-9141-8A626699625AQ34281931-F2DAE4A2-7B1E-4E64-A65B-D006D8E36FE6Q34281936-FF67EFF6-A405-4D3B-8E17-29DC5BC12D6BQ34424162-B29755C5-AA99-4B6F-BE1F-4A9418EBEA8DQ34424168-2AED991A-7A2E-449A-AEB7-0E1DBA54EB92Q35595715-84592506-D93D-4921-B41B-C269982A8B93Q35670666-5C3EFD85-2EE9-4B1E-AB67-176EB73CC211Q36143500-E2EAC47C-B0B9-44E7-B8BD-AC3CE956E734Q36453978-3D08BE71-F197-4436-9F78-E6B8A00D1A06Q37041880-035420BF-DDB9-4284-BB8C-CB0976308F3AQ37844184-D2B39D17-7D75-40C5-87AB-43DCCFB2DC2AQ37849251-4F6BAC5F-B448-43A0-81DF-C79E340BA77CQ37872968-D62200FC-DAAA-4150-9ACD-7745D84EF4FA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katherine Deane
@af
Katherine Deane
@an
Katherine Deane
@ast
Katherine Deane
@bar
Katherine Deane
@bm
Katherine Deane
@br
Katherine Deane
@ca
Katherine Deane
@co
Katherine Deane
@cs
Katherine Deane
@cy
type
label
Katherine Deane
@af
Katherine Deane
@an
Katherine Deane
@ast
Katherine Deane
@bar
Katherine Deane
@bm
Katherine Deane
@br
Katherine Deane
@ca
Katherine Deane
@co
Katherine Deane
@cs
Katherine Deane
@cy
altLabel
K Deane
@en
K H Deane
@en
KH Deane
@en
KHO Deane
@en
Katherine Deane
@en
prefLabel
Katherine Deane
@af
Katherine Deane
@an
Katherine Deane
@ast
Katherine Deane
@bar
Katherine Deane
@bm
Katherine Deane
@br
Katherine Deane
@ca
Katherine Deane
@co
Katherine Deane
@cs
Katherine Deane
@cy
P106
P21
P31
P496
0000-0002-0805-2708